Skip to main content
Erschienen in: Pediatric Nephrology 3/2012

01.03.2012 | Original Article

Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome

verfasst von: Patricia G. Vallés, Silvia Melechuck, Adriana González, Walter Manucha, Victoria Bocanegra, Roberto Vallés

Erschienen in: Pediatric Nephrology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Lipopolysaccharide stimulation of toll-like receptor 4 (TLR4) activates signal transduction pathways leading to proinflammatory cytokine secretion. We investigated TLR4 surface receptor expression on peripheral blood neutrophils and monocytes and their ability to modulate inflammatory cytokine release in 15 patients 1, 3, and 10 days after hemolytic uremic syndrome (HUS) onset. Seven patients with Escherichia coli (EHEC)-associated diarrhea and seven healthy controls were also studied. Isolated leucocytes from HUS-onset patients exhibited significantly higher messenger RNA (mRNA) TLR4 expression than controls. Moreover, TLR4 protein expression on neutrophils, determined by flow cytometry, was upregulated, driving dependent proinflammatory cytokine, tumor necrosis factor alpha (TNF-α), and interleukin 8 (IL-8) increase, and decreased anti-inflammatory IL-10 release at HUS onset compared with patients with EHEC diarrhea and controls. TLR4 expression on neutrophils was positively correlated with serum TNF-α levels. Conversely, significant reduction of neutrophil TLR4 receptor expression and lack of cytokine-responsive element activation was shown in patients 3 and 10 days after HUS onset. No differences were demonstrated in TLR4 receptor expression on monocytes among the studied groups. Our results suggest TLR4 expression may be differently regulated on neutrophils and monocytes. They could be dynamically modulated across the early development of HUS on neutrophils, resulting in negative regulation preceded by TLR4 overactivation.
Literatur
1.
Zurück zum Zitat Paton JC, Paton AW (1998) Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 11:450–479PubMed Paton JC, Paton AW (1998) Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 11:450–479PubMed
2.
Zurück zum Zitat Sheiring J, Andreoli SP, Zimmerhack LB (2008) Treatment and outcome of Shiga-toxin-associated haemolytic uremic syndrome (HUS). Pediatr Nephrol 23:1749–1760CrossRef Sheiring J, Andreoli SP, Zimmerhack LB (2008) Treatment and outcome of Shiga-toxin-associated haemolytic uremic syndrome (HUS). Pediatr Nephrol 23:1749–1760CrossRef
3.
Zurück zum Zitat Proulx F, Seidman EG, Karpman D (2001) Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr Res 50:163–171PubMedCrossRef Proulx F, Seidman EG, Karpman D (2001) Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr Res 50:163–171PubMedCrossRef
4.
Zurück zum Zitat Zoja C, Angioletti S, Donadelli R, Zanchi C, Tomasoni S, Binda E, Imberti B, Loo M, Monnens L, Remuzzi G, Morigi M (2002) Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. Kidney Int 62:846–856PubMedCrossRef Zoja C, Angioletti S, Donadelli R, Zanchi C, Tomasoni S, Binda E, Imberti B, Loo M, Monnens L, Remuzzi G, Morigi M (2002) Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. Kidney Int 62:846–856PubMedCrossRef
5.
Zurück zum Zitat Exeni RA, Fernandez GC, Palermo MS (2007) Role of polymorphonuclear leukocytes in the pathophysiology of typical hemolytic uremic syndrome. Scientific World Journal 7:1155–1164PubMedCrossRef Exeni RA, Fernandez GC, Palermo MS (2007) Role of polymorphonuclear leukocytes in the pathophysiology of typical hemolytic uremic syndrome. Scientific World Journal 7:1155–1164PubMedCrossRef
6.
Zurück zum Zitat Landoni V, Campos-Nebel M, Schierloh P, Calatayud C, Fernandez GCM, Ramos V, Rearte B, Palermo MS, Isturiz MA (2010) Shiga Toxin 1-Induced Inflammatory Response in Lipopolysaccharide-Sensitized Astrocytes Is Mediated by Endogenous Tumor Necrosis Factor Alpha. Infect Immun 78:1193–1201PubMedCrossRef Landoni V, Campos-Nebel M, Schierloh P, Calatayud C, Fernandez GCM, Ramos V, Rearte B, Palermo MS, Isturiz MA (2010) Shiga Toxin 1-Induced Inflammatory Response in Lipopolysaccharide-Sensitized Astrocytes Is Mediated by Endogenous Tumor Necrosis Factor Alpha. Infect Immun 78:1193–1201PubMedCrossRef
7.
Zurück zum Zitat Palermo M, Alves-Rosa F, Rubel C, Fernández GC, Fernández-Alonso G, Alberto F, Rivas M, Isturiz M (2000) Pretreatment of mice with lipopolysaccharide (LPS) or IL-1β exerts dose-depend.ent opposite effects on Shiga toxin-2 lethality. Clin Exp Immunol 119:77–83PubMedCrossRef Palermo M, Alves-Rosa F, Rubel C, Fernández GC, Fernández-Alonso G, Alberto F, Rivas M, Isturiz M (2000) Pretreatment of mice with lipopolysaccharide (LPS) or IL-1β exerts dose-depend.ent opposite effects on Shiga toxin-2 lethality. Clin Exp Immunol 119:77–83PubMedCrossRef
8.
Zurück zum Zitat Clayton F, Pysher TJ, Lou R, Kohan DE, Denkers ND, Tesh VL, Taylor FB Jr, Siegler RL (2005) Lipopolysaccharide upregulates renal shiga toxin receptors in a primate model of hemolytic uremic syndrome. Am J Nephrol 25:536–540PubMedCrossRef Clayton F, Pysher TJ, Lou R, Kohan DE, Denkers ND, Tesh VL, Taylor FB Jr, Siegler RL (2005) Lipopolysaccharide upregulates renal shiga toxin receptors in a primate model of hemolytic uremic syndrome. Am J Nephrol 25:536–540PubMedCrossRef
10.
Zurück zum Zitat Kawai T, Takeuchi O, Fujita T, Inoue J, Mühlradt PF, Sato S, Hoshino K, Akira S (2001) Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167:5887–5894PubMed Kawai T, Takeuchi O, Fujita T, Inoue J, Mühlradt PF, Sato S, Hoshino K, Akira S (2001) Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167:5887–5894PubMed
11.
Zurück zum Zitat Jack RS, Fan X, Bernheiden M, Rune G, Ehlers M, Weber A, Kirsch G, Mentel R, Fürll B, Freudenberg M, Schmitz G, Stelter F, Schütt C (1997) Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 389:742–745PubMedCrossRef Jack RS, Fan X, Bernheiden M, Rune G, Ehlers M, Weber A, Kirsch G, Mentel R, Fürll B, Freudenberg M, Schmitz G, Stelter F, Schütt C (1997) Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 389:742–745PubMedCrossRef
12.
Zurück zum Zitat Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M (1999) MD-2 a molecule that confers lipopolysaccharide responsiveness on Toll-like Receptor 4. J Exp Med 189:1777–1782PubMedCrossRef Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M (1999) MD-2 a molecule that confers lipopolysaccharide responsiveness on Toll-like Receptor 4. J Exp Med 189:1777–1782PubMedCrossRef
13.
14.
Zurück zum Zitat Proulx F, Seidman E, Mariscalco MM, Lee K, Caroll S (1999) Increased circulating levels of lipopolysaccharide binding protein in children with Escherichia coli O157:H7 hemorrhagic colitis and hemolytic uremic syndrome. Clin Diagn Lab Immunol 6:773PubMed Proulx F, Seidman E, Mariscalco MM, Lee K, Caroll S (1999) Increased circulating levels of lipopolysaccharide binding protein in children with Escherichia coli O157:H7 hemorrhagic colitis and hemolytic uremic syndrome. Clin Diagn Lab Immunol 6:773PubMed
15.
Zurück zum Zitat Ståhl AL, Svensson M, Mörgelin M, Svanborg C, Tarr PI, Mooney JC, Watkins SL, Johnson R, Karpman D (2006) Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 108:167–176PubMedCrossRef Ståhl AL, Svensson M, Mörgelin M, Svanborg C, Tarr PI, Mooney JC, Watkins SL, Johnson R, Karpman D (2006) Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 108:167–176PubMedCrossRef
16.
Zurück zum Zitat Walters MD, Matthei IU, Kay R, Dillon MJ, Barratt TM (1989) The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol 3:130–134PubMedCrossRef Walters MD, Matthei IU, Kay R, Dillon MJ, Barratt TM (1989) The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol 3:130–134PubMedCrossRef
17.
Zurück zum Zitat Litalien C, Proulx F, Mariscalco MM, Robitaille P, Turgeon JP, Orrbine E, Rowe PC, McLaine PN, Seidman E (1999) Circulating inflammatory cytokine levels in haemolytic uremic syndrome. Pediatr Nephrol 13:840–845PubMedCrossRef Litalien C, Proulx F, Mariscalco MM, Robitaille P, Turgeon JP, Orrbine E, Rowe PC, McLaine PN, Seidman E (1999) Circulating inflammatory cytokine levels in haemolytic uremic syndrome. Pediatr Nephrol 13:840–845PubMedCrossRef
18.
Zurück zum Zitat Westerholt S, Hartung T, Tollens M, Güstrau A, Oberhoffer M, Karch H, Klare B, Pfeffer K, Emmrich P, Oberhoffer R (2000) Inflammatory and immunological parameters in children with haemolytic uremic syndrome and gastroenteritis pathophysiological clues. Cytokine 12:822–827PubMedCrossRef Westerholt S, Hartung T, Tollens M, Güstrau A, Oberhoffer M, Karch H, Klare B, Pfeffer K, Emmrich P, Oberhoffer R (2000) Inflammatory and immunological parameters in children with haemolytic uremic syndrome and gastroenteritis pathophysiological clues. Cytokine 12:822–827PubMedCrossRef
19.
Zurück zum Zitat Vallés PG, Pesle S, Piovano L, Davila E, Peralta M, Principi I, Lo Giudice P (2005) Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock. Medicina (B Aires) 65:395–401 Vallés PG, Pesle S, Piovano L, Davila E, Peralta M, Principi I, Lo Giudice P (2005) Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock. Medicina (B Aires) 65:395–401
20.
Zurück zum Zitat Roger T, Froidevaux C, Le Roy D, Reymond MK, Chanson AL, Mauri D, Burns K, Riederer BM, Akira S, Calandra T (2009) Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci USA 106:2348–2352PubMedCrossRef Roger T, Froidevaux C, Le Roy D, Reymond MK, Chanson AL, Mauri D, Burns K, Riederer BM, Akira S, Calandra T (2009) Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci USA 106:2348–2352PubMedCrossRef
21.
22.
Zurück zum Zitat Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity 124:783–801 Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity 124:783–801
23.
Zurück zum Zitat Beutler B, Rietschel ET (2003) Innate immune sensing and its roots: The story of endotoxin. Nat Rev Immunol 3:169–176PubMedCrossRef Beutler B, Rietschel ET (2003) Innate immune sensing and its roots: The story of endotoxin. Nat Rev Immunol 3:169–176PubMedCrossRef
24.
Zurück zum Zitat Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are 23- hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J Immunol 162:3749–3752PubMed Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are 23- hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J Immunol 162:3749–3752PubMed
25.
Zurück zum Zitat Sémiramoth N, Gleizes A, Turbica I, Sandré C, Gorges R, Kansau I, Servin A, Chollet-Martin S (2009) Escherichia coli type 1 pili trigger late IL-8 production by neutrophil-like differentiated PLB-985 cells through a Src family kinase- and MAPK-dependent mechanism. J Leukoc Biol 85:310–321PubMedCrossRef Sémiramoth N, Gleizes A, Turbica I, Sandré C, Gorges R, Kansau I, Servin A, Chollet-Martin S (2009) Escherichia coli type 1 pili trigger late IL-8 production by neutrophil-like differentiated PLB-985 cells through a Src family kinase- and MAPK-dependent mechanism. J Leukoc Biol 85:310–321PubMedCrossRef
26.
Zurück zum Zitat Kevin R, Kasten KR, Muenzer JT, Caldwell CC (2010) Neutrophils are significant producers of IL-10 during sepsis. Biochem Biophys Res Commun 393:28–31CrossRef Kevin R, Kasten KR, Muenzer JT, Caldwell CC (2010) Neutrophils are significant producers of IL-10 during sepsis. Biochem Biophys Res Commun 393:28–31CrossRef
27.
Zurück zum Zitat Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, Ishizaka A, Abraham E (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290:C917–C924PubMedCrossRef Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, Ishizaka A, Abraham E (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290:C917–C924PubMedCrossRef
28.
Zurück zum Zitat Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248–251PubMedCrossRef Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248–251PubMedCrossRef
29.
Zurück zum Zitat Härter L, Mica L, Stocker R, Trentz O, Keel M (2004) Increased expression of toll-like receptor-2 and −4 on leukocytes from patients with sepsis. Shock 22:403–409PubMedCrossRef Härter L, Mica L, Stocker R, Trentz O, Keel M (2004) Increased expression of toll-like receptor-2 and −4 on leukocytes from patients with sepsis. Shock 22:403–409PubMedCrossRef
30.
Zurück zum Zitat Brandl K, Glück T, Huber C, Salzberger B, Falk W, Hartmann P (2005) TLR-4 surface display on human monocytes is increased in septic patients. Eur J Med Res 10:319–324PubMed Brandl K, Glück T, Huber C, Salzberger B, Falk W, Hartmann P (2005) TLR-4 surface display on human monocytes is increased in septic patients. Eur J Med Res 10:319–324PubMed
31.
Zurück zum Zitat Brunialti MK, Martins PS, Barbosa de Carvalho H, Machado FR, Barbosa LM, Salomao R (2006) TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis and septic shock. Shock 25:351–357PubMedCrossRef Brunialti MK, Martins PS, Barbosa de Carvalho H, Machado FR, Barbosa LM, Salomao R (2006) TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis and septic shock. Shock 25:351–357PubMedCrossRef
32.
Zurück zum Zitat Martins PS, Brunialti MK, Martos LS, Machado FR, Assunçao MS, Blecher S, Salomao R (2008) Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis. Crit Care 12:R25PubMedCrossRef Martins PS, Brunialti MK, Martos LS, Machado FR, Assunçao MS, Blecher S, Salomao R (2008) Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis. Crit Care 12:R25PubMedCrossRef
33.
Zurück zum Zitat Fernandez G, Gómez SA, Rubel C, Bentancor LV, Barrionuevo P, Alduncín M, Grimoldi I, Exeni R, Isturiz MA, Palermo MS (2005) Impaired neutrophils (PMN) in children with the typical form of haemolytic uremic syndrome (D-HUS). Pediatr Nephrol 20:1306–1314PubMedCrossRef Fernandez G, Gómez SA, Rubel C, Bentancor LV, Barrionuevo P, Alduncín M, Grimoldi I, Exeni R, Isturiz MA, Palermo MS (2005) Impaired neutrophils (PMN) in children with the typical form of haemolytic uremic syndrome (D-HUS). Pediatr Nephrol 20:1306–1314PubMedCrossRef
34.
Zurück zum Zitat Bazil V, Strominger JL (1991) Shedding as a mechanism of downmodulation of CD14 on stimulated human monocytes. J Immunol 147:1567–1574PubMed Bazil V, Strominger JL (1991) Shedding as a mechanism of downmodulation of CD14 on stimulated human monocytes. J Immunol 147:1567–1574PubMed
35.
Zurück zum Zitat Beigier-Bompadre M, Barrionuevo P, Alves-Rosa F, Rubel CJ, Palermo MS, Isturiz MA (2003) The formyl peptide N-formyl-methionyl-leucyl-phenylalanine downregulates the expression of FcgammaRs in interferon-gamma-activated monocytes/macrophages in vitro and in vivo. Scand J Immunol 57:221–228PubMedCrossRef Beigier-Bompadre M, Barrionuevo P, Alves-Rosa F, Rubel CJ, Palermo MS, Isturiz MA (2003) The formyl peptide N-formyl-methionyl-leucyl-phenylalanine downregulates the expression of FcgammaRs in interferon-gamma-activated monocytes/macrophages in vitro and in vivo. Scand J Immunol 57:221–228PubMedCrossRef
36.
Zurück zum Zitat Fernandez GC, Rubel C, Barrionuevo P, Lopez L, Ramirez F, Diaz M, Isturiz MA, Palermo MS (2002) Phenotype markers and function of neutrophils in children with hemolytic uremic syndrome. Pediatr Nephrol 17:337–344PubMedCrossRef Fernandez GC, Rubel C, Barrionuevo P, Lopez L, Ramirez F, Diaz M, Isturiz MA, Palermo MS (2002) Phenotype markers and function of neutrophils in children with hemolytic uremic syndrome. Pediatr Nephrol 17:337–344PubMedCrossRef
37.
Zurück zum Zitat Kaplan BS, Mills M (1988) Elevated serum elastase and −1-antitrypsin levels in hemolytic uremic syndrome. Clin Nephrol 30:193–196PubMed Kaplan BS, Mills M (1988) Elevated serum elastase and −1-antitrypsin levels in hemolytic uremic syndrome. Clin Nephrol 30:193–196PubMed
38.
Zurück zum Zitat Fernández GC, Ramos MV, Gómez SA, Dran GI, Exeni R, Alduncín M, Grimoldi I, Vallejo G, Elías-Costa C, Isturiz MA, Palermo MS (2005) Differential expression of function-related antigens on blood monocytes in children with hemolytic uremic syndrome. J Leukoc Biol 78:853–861PubMedCrossRef Fernández GC, Ramos MV, Gómez SA, Dran GI, Exeni R, Alduncín M, Grimoldi I, Vallejo G, Elías-Costa C, Isturiz MA, Palermo MS (2005) Differential expression of function-related antigens on blood monocytes in children with hemolytic uremic syndrome. J Leukoc Biol 78:853–861PubMedCrossRef
39.
Zurück zum Zitat Liew FY, Xu D, Brint EK, O'Neill LA (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5:446–458PubMedCrossRef Liew FY, Xu D, Brint EK, O'Neill LA (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5:446–458PubMedCrossRef
Metadaten
Titel
Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome
verfasst von
Patricia G. Vallés
Silvia Melechuck
Adriana González
Walter Manucha
Victoria Bocanegra
Roberto Vallés
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 3/2012
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-011-2014-7

Weitere Artikel der Ausgabe 3/2012

Pediatric Nephrology 3/2012 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.